Clinical Trial Detail

NCT ID NCT04166409
Title A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications

astrocytoma

malignant glioma

Therapies

Selumetinib

Carboplatin + Vincristine Sulfate

Age Groups: child adult

Additional content available in CKB BOOST